Northwest Investment Counselors LLC Grows Holdings in Agilent Technologies, Inc. (NYSE:A)

Northwest Investment Counselors LLC increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 0.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,760 shares of the medical research company’s stock after buying an additional 155 shares during the period. Northwest Investment Counselors LLC’s holdings in Agilent Technologies were worth $3,528,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in A. Crewe Advisors LLC increased its position in shares of Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies in the 3rd quarter worth approximately $28,000. Ridgewood Investments LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $29,000. Ashton Thomas Private Wealth LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $39,000. Finally, Riverview Trust Co bought a new stake in shares of Agilent Technologies in the 1st quarter worth approximately $41,000. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,953 shares of company stock worth $2,013,630. Corporate insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

A has been the topic of a number of research reports. Barclays boosted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a report on Tuesday, October 15th. Bank of America boosted their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. UBS Group upped their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. TD Cowen lifted their price target on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Finally, Stifel Nicolaus restated a “buy” rating and issued a $151.00 target price on shares of Agilent Technologies in a research note on Monday, August 26th. One analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $144.36.

Agilent Technologies Trading Down 1.6 %

Shares of A stock traded down $2.18 during trading hours on Monday, reaching $136.65. The company had a trading volume of 436,718 shares, compared to its average volume of 1,683,360. The company has a 50 day moving average of $141.02 and a 200 day moving average of $138.73. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The firm has a market cap of $39.87 billion, a price-to-earnings ratio of 32.82, a P/E/G ratio of 6.96 and a beta of 1.05. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm’s revenue was down 5.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.43 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be issued a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.